ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Curatis Holding AG

Curatis Holding AG (0QNS)

0.023
0.00
(0.00%)
終了 7月9日 12:30AM

Curatis Holding AG (0QNS) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
0.023
( - )
買値
0.023
売値
0.023
出来高
1
平均取引量 (3 か月)
CHF 3,839
財務取引量
-
0.00 日の範囲 0.00
0.023 52 週間の範囲 0.023
時価総額
企業価値
123.241M
前日終値
0.023
始値
-
最終取引時間
VWAP
-
歳入
10.8M
純利益
-1.42M
発行済株式数
5,301,199
浮動株比率 (%)
21.91%
機関投資家保有比率 (%)
4.03%
配当利回り
PER
-83.14
株価売上高倍率 (PSR)
11.58
1 株当たり利益 (EPS)
-0.28
ベータ
-0.77

Curatis Holding AG について

Curatis Holding AG engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases. It offers its products in the areas of fentanyl, breakthrough pain, antiplatelet, metastatic hormone receptor-positive brea... Curatis Holding AG engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases. It offers its products in the areas of fentanyl, breakthrough pain, antiplatelet, metastatic hormone receptor-positive breast cancer, anti-arrhythmic, nasal oil, wilson’s disease, cyanide poisoning, digoxin toxicity, antihypotensive, bladder pain syndrome/intersticial cystitis, antibioticum, diagnostic ophthalmology, antiviral, ophtalmic/ antibioticum, gentamycin collagen sponge, benign prostatic hyperplasia, immunomodulator, epilepsy and essential tremor, thyreostatic, hereditary tyrosinemia type 1, nootropic, tranquilizer, helicobacter pylori test, phosphate binder, special nutrition for dialysis patients, dermato corticosteroid, lead and mercury poisoning, corticostimulin, anti-fog agent, chorea associated with huntington’s disease, and antiepileptic. The company also develops C-PTBE-01, which is in Phase IIb clinical trial for the treatment of peritumoral brain edema; C-AM-01 that is in Phase IIa clinical trial for the prevention of severe migraine with aura; C-MOH-01, which is in Phase IIa clinical trial for the treatment and prevention of medication overuse headache; and C-FI-01 that is in phase I clinical trial for the treatment of fibrotic or inflammatory orphan or ultra-orphan diseases. The company was founded in 2002 and is based in Liestal, Switzerland. 詳細を表示

セクター
-
業界
-
ウェブサイト
本社
Liestal, Switzerland
設立
2026
Curatis Holding AG is listed in the sector of the ロンドン証券取引所 with ticker 0QNS. The last closing price for Curatis was CHF0.02. Over the last year, Curatis shares have traded in a share price range of CHF 0.023 to CHF 0.023.

Curatis currently has 5,301,199 shares in issue. The market capitalisation of Curatis is CHF121,927.58 . Curatis has a price to earnings ratio (PE ratio) of -83.14.

0QNS 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000DE
40000000DE
120000000DE
26000.0230.0230.0231000.023DE
52000.0230.0230.023330.023DE
156000.0230.0230.023120.023DE
260000.0230.0230.02312680.023DE

0QNS - Frequently Asked Questions (FAQ)

What is the current Curatis Holding AG share price?
The current share price of Curatis Holding AG is CHF 0.023
How many Curatis Holding AG shares are in issue?
Curatis Holding AG has 5,301,199 shares in issue
What is the market cap of Curatis Holding AG?
The market capitalisation of Curatis Holding AG is CHF 121.93k
What is the 1 year trading range for Curatis Holding AG share price?
Curatis Holding AG has traded in the range of CHF 0.023 to CHF 0.023 during the past year
What is the PE ratio of Curatis Holding AG?
The price to earnings ratio of Curatis Holding AG is -83.14
What is the cash to sales ratio of Curatis Holding AG?
The cash to sales ratio of Curatis Holding AG is 11.58
What is the registered address of Curatis Holding AG?
The registered address for Curatis Holding AG is Weierweg 7, Liestal, Basel-Landschaft, 4410
What is the Curatis Holding AG website address?
The website address for Curatis Holding AG is curatis.com

0QNS 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock